 |
BioWorld-International-2009-08-12
Many Existing Drugs Candidates in Finding Schistosomiasis Cure
Pfizer Bails from Eye Alliance, Hands Glaucoma Drug to NiCox
Almost a full year after Pfizer Inc. decided to discontinue development of PF-03187207, it finally handed the compound back to its erstwhile partner, NiCox SA, and has withdrawn from its strategic alliance in ophthalmology with the company. (BioWorld International)
French Government Puts €10M into Cancer Biomarker Research
No Abstract
BioWorld International Correspondent
Oncodesign SA is heading up a cancer biomarker consortium that has secured €10 million (US$14.1 million) from the French innovation agency OSEO to develop a new generation of tumor-specific radiotracers.